Published in J Hypertens on March 01, 2005
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol (2006) 3.74
The T(-786)C endothelial nitric oxide synthase genotype predicts cardiovascular mortality in high-risk patients. J Am Coll Cardiol (2006) 2.96
Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens (2006) 2.61
Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Hypertension (2013) 2.25
The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol (2003) 1.97
Hypertension in acute ischemic stroke: a compensatory mechanism or an additional damaging factor? Arch Intern Med (2003) 1.93
Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology (2007) 1.93
Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients. J Am Soc Nephrol (2008) 1.75
Menopause does not affect blood pressure and risk profile, and menopausal women do not become similar to men. J Hypertens (2008) 1.70
Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension (2008) 1.69
C-344T polymorphism of the aldosterone synthase gene and blood pressure in the elderly: a population-based study. J Hypertens (2005) 1.61
Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols. Hypertension (2009) 1.57
The white-coat effect is unrelated to the difference between clinic and daytime blood pressure and is associated with greater reactivity to public speaking. J Hypertens (2003) 1.54
Aldosterone and refractory hypertension: a prospective cohort study. Am J Hypertens (2006) 1.53
Renal vein renin measurements accurately identify renovascular hypertension caused by total occlusion of the renal artery. J Hypertens (2002) 1.48
Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes (2010) 1.48
The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma. J Hypertens (2010) 1.46
Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. Arterioscler Thromb Vasc Biol (2007) 1.44
Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling. Hypertens Res (2011) 1.44
Abnormal regulation of G protein alpha(i2) subunit in skin fibroblasts from insulin-resistant hypertensive individuals. J Hypertens (2004) 1.42
Effect of body weight loss on blood pressure after 6 years of follow-up in stage 1 hypertension. Am J Hypertens (2006) 1.42
Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey. J Hypertens (2002) 1.41
Blood pressure control according to new guidelines targets in low- to high-risk hypertensives managed in specialist practice. J Hypertens (2004) 1.41
Oxidative stress and post-transplant hypertension in pediatric kidney-transplanted patients. J Pediatr (2006) 1.40
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J Clin Endocrinol Metab (2008) 1.38
The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol (2003) 1.33
Antioxidant effect of L-carnitine and its short chain esters: relevance for the protection from oxidative stress related cardiovascular damage. Int J Cardiol (2006) 1.30
Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol (2008) 1.27
Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II. J Hypertens (2006) 1.20
Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course. Endocr Relat Cancer (2005) 1.20
The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediators Inflamm (2013) 1.15
Endothelial dysfunction in type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis (2006) 1.15
Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension (2007) 1.13
Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy. Cerebrovasc Dis (2007) 1.12
In vivo ozone exposure induces antioxidant/stress-related responses in murine lung and skin. Free Radic Biol Med (2004) 1.09
Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens (2006) 1.09
Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension (2002) 1.08
Angiotensin II type 1 and type 2 receptor interplay in hypertension: lesson from a human model of vascular hyporeactivity. J Hypertens (2013) 1.07
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study. J Hypertens (2010) 1.07
Dissociating angiotensin 1-9 anticardiovascular remodeling effects from those on blood pressure. J Hypertens (2014) 1.06
Inhibition of NFkappaB activation and IL-8 expression in human bronchial epithelial cells by acrolein. Antioxid Redox Signal (2005) 1.06
Metformin prevents glucose-induced protein kinase C-beta2 activation in human umbilical vein endothelial cells through an antioxidant mechanism. Diabetes (2005) 1.05
Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis. Hypertension (2007) 1.04
In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study. Crit Care (2010) 1.04
Low-density lipoprotein cholesterol and mortality in older people. J Am Geriatr Soc (2005) 1.03
Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II. J Am Coll Cardiol (2003) 1.02
Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am J Hypertens (2010) 1.02
Callipeltin A: sodium ionophore effect and tension development in vascular smooth muscle. Biochem Pharmacol (2004) 0.99
Angiotensin II-stimulated collagen production in cardiac fibroblasts is mediated by reactive oxygen species. J Hypertens (2006) 0.99
At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways. Aging Cell (2010) 0.98
Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism. J Hypertens (2012) 0.98
Phosphate binders and management of hyperphosphataemia in end-stage renal disease. Nephrol Dial Transplant (2006) 0.97
Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis. Hepatology (2004) 0.97
Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens (2007) 0.96
Adiponectin receptor expression in the human adrenal cortex and aldosterone-producing adenomas. Int J Mol Med (2006) 0.95
Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress. J Clin Endocrinol Metab (2003) 0.95
Association between coffee consumption and risk of hypertension. Ann Med (2007) 0.94
Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension. J Hypertens (2010) 0.93
Cigarette smoke exposure causes changes in Scavenger Receptor B1 level and distribution in lung cells. Int J Biochem Cell Biol (2009) 0.93
Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives. Arterioscler Thromb Vasc Biol (2004) 0.92
A review of the physiological and immunological functions of biliary epithelial cells: targets for primary biliary cirrhosis, primary sclerosing cholangitis and drug-induced ductopenias. Clin Dev Immunol (2004) 0.91
Induction of stress proteins and MMP-9 by 0.8 ppm of ozone in murine skin. Biochem Biophys Res Commun (2003) 0.91
The redox enzyme p66Shc contributes to diabetes and ischemia-induced delay in cutaneous wound healing. Diabetes (2010) 0.91
Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept. Autoimmun Rev (2008) 0.91
Prevalence and clinical significance of isolated ambulatory hypertension in young subjects screened for stage 1 hypertension. Hypertension (2004) 0.90
Vitamin C prevents zidovudine-induced NAD(P)H oxidase activation and hypertension in the rat. Cardiovasc Res (2006) 0.90
Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes. J Clin Endocrinol Metab (2004) 0.90
Body mass index and mortality in elderly men and women from general population. The experience of Cardiovascular Study in the Elderly (CASTEL). Gerontology (2006) 0.90
Modulation of cutaneous wound healing by ozone: differences between young and aged mice. Toxicol Lett (2005) 0.89
Effects of angiotensin II and insulin on ERK1/2 activation in fibroblasts from hypertensive patients. Am J Hypertens (2004) 0.89
Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients. J Clin Endocrinol Metab (2008) 0.89
Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma. Hypertension (2012) 0.89
Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension. J Clin Endocrinol Metab (2004) 0.89
Almonds and almond oil have similar effects on plasma lipids and LDL oxidation in healthy men and women. J Nutr (2002) 0.89
An abnormal gene expression of the beta-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats. Hepatology (2008) 0.88
Urine therapy through the centuries. J Nephrol (2011) 0.88